Bioklone is an antibody service provider located in the Biotech Park, Chennai, India. It was founded in 2006 by Dr. K. Rajeshwari with the main goal of providing reliable custom antibody services to Life science researchers across India. Ever since its inception in 2006 the firm’s underlying objective has been to deliver end-user centric and cost effective antibodies through a highly interactive and customised approach. The firm has been providing custom antibody services as well as assay development solutions for research, diagnostic and pharmaceutical applications. It has an excellent animal house facility and well equipped cell culture and laboratory facilities manned by experienced staff.
The firm is led by its Founder and Managing Director, Dr. K. Rajeshwari. She obtained her Ph. D from Indian Institute of Science (IISc), Bangalore in 1998 following which she carried out post-doctoral research at Thomas Jefferson University, Philadelphia, USA. After her return to India, she was a Visiting Fellow at Tata Institute of Fundamental Research (TIFR), Mumbai. During her research tenures in IISc and TIFR, she successfully developed several monoclonal and polyclonal antibodies to a range of complex peptides, proteins, drugs, small molecules and whole cells. Her close interactions with the scientists and research students in the two institutes for over twelve years helped Dr. Rajeshwari understand the actual antibody needs of researchers and the practical problems faced by them due to non-availability of reliable and timely supplies of custom and commercial antibodies. This gap in the demand and timely supply of high quality and cost-effective antibodies was the major driving force behind the inception of the firm in 2006.
The technical expertise of Dr. Rajeshwari in the field of hybridoma and T. Venkataramani’s experience in management and technology along with the firm’s excellent team have been the key factors in the consistent growth and success of the firm. The back-bone of the firm is its technical team comprising of highly motivated and committed members qualified in various areas of Life Sciences and Biotechnology. Since 2006, the firm’s antibody services have been utilized by several scientists in premier research institutes, clinical organizations, diagnostic and pharmaceutical companies across India for development of monoclonal and polyclonal antibodies against multiple molecules including drugs, small molecules, peptides, proteins and whole cells.
The firm’s services have been appreciated by several scientists who have found the services to be -
- Highly interactive.
- End-user centric.